Page 2033 - Cote clinical veterinary advisor dogs and cats 4th
P. 2033

Urolithiasis, Oxalate   1015


             renal excretion of calcium, or increased   ○   Shape varies from spiculated (dihydrate)   •  Mechanical  removal  of  bladder/urethral
             resorption of calcium from bone with or   to smooth (monohydrate). The perineum   calculi producing clinical signs; radiographs
  VetBooks.ir  •  Hypercalcemia is identified in 20%-35% of   Advanced or Confirmatory Testing  complete removal.     Diseases and   Disorders
                                                  must be included in the radiographic field
             without hypercalcemia.
                                                                                    should be repeated afterward to ensure
                                                  to identify uroliths in the urethra.
             cats and ≈4% of dogs with calcium oxalate
                                                                                    ○   Urohydropropulsion (voiding, retrograde
             urolithiasis. Hypercalcemia in cats with
             calcium oxalate uroliths is usually idiopathic   •  Abdominal ultrasound: little benefit beyond   [pp. 1175 and 1176]); avoid performing
                                                                                      voiding urohydropropulsion in male cats.
             in nature; hypercalcemia in dogs with   abdominal  radiography  but  can  confirm   ○   Catheter-assisted retrieval
             calcium oxalate uroliths is usually associated   location,  assess kidneys  for evidence of   ○   Cystoscopic-assisted retrieval (p. 1085)
             with primary hyperparathyroidism.  pyelonephritis or hydronephrosis    ○   Cystotomy/urethrotomy/urethrostomy/
           •  Hyperadrenocorticism  associated  with   •  Urolith  analysis:  retrieved  stones  should   pyelotomy/nephrotomy/ureterectomy
             calcium oxalate uroliths in dogs may or   be submitted for quantitative analysis   with neoureterocystostomy, ureteral stent,
             may not be associated with hypercalcemia.  (crystallography, x-ray diffraction, infrared   or  subcutaneous  ureteral  bypass  device
           •  Hyperoxaluria in cats may be related to diet,   spectroscopy) to determine urolith type.  implantation
             inadequate vitamin B 6 , and hepatic enzyme   •  Urolith  culture:  if  urine culture  by  cysto-  ○   Lithotripsy, intracorporeal or extracorporeal
             deficiencies.                      centesis is negative                  shock wave lithotripsy
           •  Urolith  formation  is  potentiated  by   •  Cystoscopy with or without laser lithotripsy   •  Calcium oxalate is the most common type
             diminished concentrations of urinary   may facilitate stone removal for analysis and   of nephrolith/ureterolith. Because surgical
             crystallization inhibitors (e.g., nephrocalcin,   therapy (p. 1085).   removal of nephroliths can reduce renal func-
             citrate, pyrophosphate, glycosaminoglycans,   •  Specific diagnostic tests may be indicated to   tion (p. 689), it is not uniformly indicated.
             Tamm-Horsfall mucoprotein).        identify predisposing conditions (e.g., ionized
           •  Diets with moderate fat and carbohydrate   calcium concentration, parathyroid hormone   Chronic Treatment
             levels: increased risk of calcium oxalate stone   assay, adrenal function testing).  •  Identify underlying disorder (e.g., hyperadre-
             formation (vs. diminished risk for diets high                          nocorticism, hyperparathyroidism) if present,
             in moisture with  a moderate  magnesium,    TREATMENT                  and treat appropriately.
             phosphorus, and calcium content)                                     •  For  cats  with  idiopathic  hypercalcemia,
                                               Treatment Overview                   high-fiber diet may be beneficial. To simul-
            DIAGNOSIS                          Urethral obstruction requires immediate relief.   taneously alkalinize the urine, add potassium
                                               Oxalate stones cannot be dissolved with medical   citrate 75 mg/kg PO q 12h, adjusted so urine
           Diagnostic Overview                 therapy, and uroliths in the bladder or urethra   pH = 6.5-7.0. Bisphosphonates (alendronate)
           Diagnosis is suspected in animals with   should be removed mechanically if they are   may  help  control  hypercalcemia:  initially
           radiopaque bladder stones and acidic urine   causing clinical signs. Recurrence is common   2 mg/kg PO once weekly. Most cats respond
           or in animals with radiopaque nephroliths.   (up to 50% in 3 years in dogs).  to 10 mg/CAT. Follow with at least 6 mL
           Quantitative stone analysis is necessary for con-                        of water PO after administration, and
           firmation and an optimal treatment/prevention   Acute General Treatment  butter  the  lips  to  increase  salivation  and
           plan. More than 50% of patients with active   •  Relieve urethral obstruction (pp. 1175 and   increase transit. Effects, if seen, occur in
           calcium oxalate uroliths do not have concurrent   1176).                 3-4 weeks. Monitor serum ionized calcium
           crystalluria. A global approach to diagnosis and   •  Antibiotics  (choice  based  on  culture  and   (p. 491).
           management is outlined on p. 1455.   susceptibility) if secondary UTI  •  Initiate measures to prevent recurrence (see
                                               •  If  uroliths  are  found  incidentally  in  the   Prevention below).
           Differential Diagnosis               absence of clinical signs, it is reasonable
           •  UTI, bacterial or fungal (p. 232)  to omit removal and begin prevention to   Nutrition/Diet
           •  Other types of uroliths           minimize growth of uroliths, including   •  Avoid calcium supplements, acidifying diets,
           •  Urinary tract neoplasia (p. 991)  regular follow-up for urinalysis, urine culture,   and foods high in oxalate such as green leafy
                                                and radiography.                    vegetables.
           Initial Database
           •  CBC: unremarkable
           •  Serum  biochemistry  profile  (including
             electrolytes) typically unremarkable
             ○   Hypercalcemia or evidence of endocri-
               nopathy: uncommon
             ○  Azotemia,  hyperkalemia,  metabolic
               acidosis if urinary tract obstruction
           •  Urinalysis: acidic to neutral pH unless UTI;
             crystalluria (< 50%); hematuria and/or pyuria
             (occasional)
             ○   Storage of urine may lead to precipitation
               of oxalate crystals (artifact); urine sediment
               should be examined within 1 hour of
               collection.
             ○   Urine bacterial culture and susceptibility
               to rule out secondary infection
           •  Abdominal radiographs: radiopaque calculi
             most commonly located in bladder, some-  UROLITHIASIS, OXALATE  Lateral abdominal radiograph of a dog with two large, irregular, mineral-opacity
             times urethra, ureter, or renal pelvis  structures (large arrows) in the urinary bladder that are consistent with oxalate uroliths. A mineral opacity in the
             ○   Relative radiopacity of uroliths: struvite   region of a ureter (small single arrow) and mineral opacities in both kidneys (small arrows) are also consistent
               ≥ oxalate  = CaPO 4   ≥ silica  > cystine    with oxalate urolithiasis, but a dorsoventral or ventrodorsal view is necessary to differentiate ureterolithiasis
               > urate                         from mineral in the gastrointestinal tract.

                                                      www.ExpertConsult.com
   2028   2029   2030   2031   2032   2033   2034   2035   2036   2037   2038